Takeda invests in continuous processing; Actavis recalls metformin;

> Takeda Ventures is investing €3 million ($3.3 million) in Belgium-based Univercells and will tailor Univercells' continuous integrated manufacturing methods for Takeda's vaccines production processes. Release

> India's National Dairy Development Board has started manufacturing from a new $38.6 million animal and human vaccine manufacturing plant near Hyderabad. Story

> Pharmaceutical production increased 29.2% in Singapore for the 12 months ending Sept. 30, coming off a low base the year before. Story

> Actavis is recalling more than 13,280 bottles of metformin after a lot failed dissolution testing. Recall

> Canada's Apotex is recalling 28,802 bottles of Bromfenac Ophthalmic Solution after lots failed preservative effectiveness testing. Recall

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.